These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 32005122)

  • 1. Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease.
    Williams T; Borchelt DR; Chakrabarty P
    Mol Neurodegener; 2020 Jan; 15(1):8. PubMed ID: 32005122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE effects on regional tau in preclinical Alzheimer's disease.
    Young CB; Johns E; Kennedy G; Belloy ME; Insel PS; Greicius MD; Sperling RA; Johnson KA; Poston KL; Mormino EC; ;
    Mol Neurodegener; 2023 Jan; 18(1):1. PubMed ID: 36597122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
    Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
    Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
    J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of ApoE4 on the Pathogenesis in Alzheimer's Disease and the Potential Therapeutic Approaches.
    Sun YY; Wang Z; Huang HC
    Cell Mol Neurobiol; 2023 Oct; 43(7):3115-3136. PubMed ID: 37227619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β.
    Chai AB; Lam HHJ; Kockx M; Gelissen IC
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158980. PubMed ID: 34044125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
    Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
    Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk.
    Tai LM; Mehra S; Shete V; Estus S; Rebeck GW; Bu G; LaDu MJ
    Mol Neurodegener; 2014 Jan; 9():2. PubMed ID: 24386905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Insight into the Therapeutic Promise of Targeting
    Mamun AA; Uddin MS; Bin Bashar MF; Zaman S; Begum Y; Bulbul IJ; Islam MS; Sarwar MS; Mathew B; Amran MS; Md Ashraf G; Bin-Jumah MN; Mousa SA; Abdel-Daim MM
    Oxid Med Cell Longev; 2020; 2020():5086250. PubMed ID: 32509144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice.
    Pankiewicz JE; Guridi M; Kim J; Asuni AA; Sanchez S; Sullivan PM; Holtzman DM; Sadowski MJ
    Acta Neuropathol Commun; 2014 Jun; 2():75. PubMed ID: 24972680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.
    Huang Y
    Biochem Soc Trans; 2011 Aug; 39(4):924-32. PubMed ID: 21787325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
    Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T
    J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
    Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
    J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.
    Huang Y
    Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease.
    Li Y; Macyczko JR; Liu CC; Bu G
    Neurobiol Aging; 2022 Jul; 115():20-28. PubMed ID: 35453035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease.
    Saul A; Wirths O
    Mol Neurobiol; 2017 Jan; 54(1):319-327. PubMed ID: 26742512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
    Butterfield DA; Mattson MP
    Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.
    Thangavel R; Bhagavan SM; Ramaswamy SB; Surpur S; Govindarajan R; Kempuraj D; Zaheer S; Raikwar S; Ahmed ME; Selvakumar GP; Iyer SS; Zaheer A
    J Alzheimers Dis; 2018; 61(2):553-560. PubMed ID: 29172001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular cholesterol homeostasis and Alzheimer's disease.
    Chang TY; Yamauchi Y; Hasan MT; Chang C
    J Lipid Res; 2017 Dec; 58(12):2239-2254. PubMed ID: 28298292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.